Key result
Higher-dose ranolazine prevents ventricular arrhythmias and lengthens VERP by ~8 ms in preclinical models.
Why the study?
Ranolazine prevents acute MI ventricular arrhythmias, but predominant late Na+ current blockade in ventricles at clinical doses could potentially shorten refractoriness and aggravate reentrant ventricular arrhythmias late after an acute infarct.
Does intravenous ranolazine prevent or aggravate rapid pacing-induced reentrant ventricular arrhythmias in rabbits during the subacute phase of myocardial infarction?
Does intravenous ranolazine prevent or aggravate rapid pacing-induced reentrant ventricular arrhythmias in rabbits during the subacute phase of myocardial infarction?
In a subacute post-MI rabbit model, clinically therapeutic anti-ischemic doses of ranolazine failed to protect against and potentially aggravated reentrant ventricular arrhythmias, whereas higher doses exerted antiarrhythmic effects by prolonging ventricular refractoriness.
Answers are grounded in this paper and cite their sources.
May aggravate reentrant arrhythmias in acute MI; leaves open net clinical effect of ranolazine.
Ranolazine (R) has been reported to prevent acute myocardial infarction (MI) ventricular arrhythmias. So long as triggered activity or abnormal automaticity are suspected as causing mechanisms of such arrhythmias, Ran's action could be explained by inhibiting late Na+ current which may favor the development of early afterdepolarizations. However, since R might predominantly block late Na+ current in ventricles at clinical doses, it is possible to shorten refractoriness and aggravate reentrant ventricular arrhythmias (VAs) late after an acute infarct. In this study the effect of i.v. bolus R 2.4 mg/kg (R1) and 4.8 mg/kg cumulative dose (R2) was evaluated on inducibility and severity of rapid pacing-induced VAs. Ten anesthetized rabbits of either sex and 3–3.5 kg b.w. were effectively tested 3–7 days after creating acute MI by ligating one or two coronary arteries. VAs were evoked by high rate endocardial right ventricular stimulation using monophasic action potential catheters enabling pacing and recording simultaneously. During control (con) stimulation 2 animals developed nonsustained ventricular tachycardia (nsVT), two other animals displayed ventricular fibrillation (VF), and 6 animals sustained VT (sVT). R1 did not prevent reproducibility of VAs in any of animals. Notably, R1 degenerated nsVT into sVT while it did not hinder reinducibility of VF. In rabbits with sVT, morphology and cycle length of VT did not alter significantly (100.8±10.6 vs 98.6±12 ms, con vs. R1, p=NS); in 2 of these animals sVT culminated into protracted VT and VF. Ventricular effective refractory period (VERP) remained almost unchanged after R1 (111.7±5 vs 110.6 ms, p=NS). In comparison, R2 prevented inducibility of nsVT and VF. It significantly increased VERP to 120±7 ms (p=.004) and prolonged sVT cycle length to 150.8±22.9 ms in 4 animals while in the remaining 2 animals sVT was not reinducible. In conclusion, R at doses ranging within clinically therapeutic settings did not protect against VAs produced in the subacute stage of MI in this rabbit model. However, higher doses seem to exert antiarrhythmic effects as indicated by slowing sVT or by hindering its reinducibility. These findings may suggest that post-infarct patients receiving anti-ischemic doses of R could eventually be exposed to a higher risk for developing malignant VAs.
No takes yet. Share an insight, caveat, or question.
Aidonidis et al. (2018) studied Subacute/late myocardial infarction with inducible reentrant ventricular arrhythmias (rabbit model) (n=10). Ranolazine vs. Baseline control stimulation prior to ranolazine administration was evaluated on Inducibility and severity of rapid pacing-induced ventricular arrhythmias (VAs) and ventricular effective refractory period (VERP) (p=0.004). Ranolazine at /kg failed to prevent ventricular arrhythmias, whereas /kg prevented nsVT/VF and increased VERP from 111.7±5 to 120±7 ms.
Synapse has enriched 10 related papers. Consider them for comparative context: